Tuesday, December 31, 2024
Happening Now

Companies race to develop COVID-19 monoclonal antibody treatment

In contrast to the convalescent plasma taken from survivors’ blood, monoclonal antibodies can be manufactured in large amounts in a lab. Source

Share